Hemorrhagic Fever

Hemorrhagic Fever is a topic covered in the Pocket ICU Management.

To view the entire topic, please or purchase a subscription.

Anesthesia Central is an all-in-one web and mobile solution for treating patients before, during, and after surgery. This collection of drug, procedures and test information is derived from Davis’s Drug, MGH Clinical Anesthesia Procedures, Pocket Guide to Diagnostic Tests, and MEDLINE Journals. Explore these free sample topics:

Anesthesia Central

-- The first section of this topic is shown below --

First Things First (assess & treat for the following)

  • This chapter will address viral hemorrhagic fever (VHF), defined as a febrile illness associated with bleeding diathesis caused by specific hemorrhagic fever virus (HFV) families.
  • The classic VHF presentation includes fever, skin rash, myalgias, and encephalitis.
  • Because of the nonspecific presentation, must maintain a high index of suspicion to make the diagnosis.
  • Supportive treatment is the primary mode of management.
  • Ribavirin therapy may have a role for some HFVs but has not been well studied and is not approved by the U.S. FDA.
  • Human-to-human transmission most commonly occurs by direct contact with blood or body fluids, so isolation of suspected VHF patient is imperative.
  • Health care workers should maintain strict barrier precautions and airborne precautions if available.
  • Contact local public health officials if you suspect the diagnosis.

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: May 2, 2010